Larimar Therapeutics Inc - Bla Submission Targeted for 2H 2025 for Potential Accelerated Approval
Larimar Therapeutics Inc - BLAs提交目標定於2025年下半年,以爭取潛在的加速批准
Larimar Therapeutics Inc - Bla Submission Targeted for 2H 2025 for Potential Accelerated Approval
Larimar Therapeutics Inc - BLAs提交目標定於2025年下半年,以爭取潛在的加速批准
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因